New: Hyperplex Biomarker Panels
Custom Panels for Absolute Protein Quantification
New: Hyperplex Biomarker Panels
Custom Panels for Absolute Protein Quantification
In January, we announced our new strategic partnership with Bruker to broaden access to our leading proteomics services & tools for biopharma and #biomarker customers.
In this exciting SpotLight episode, Biognosys’ CEO Oliver Rinner and Rohan Thakur, President of the Bruker Life-Science Mass Spectrometry division, discuss the many synergies of the new alliance and give an outlook of what the future might hold.
The brochure provides you with an overview of Biognosys’ history, including major milestones, our technology, as well as key facts about our offerings.
This comprehensive brochure provides an overview of our services, software, and kits offering.
Presenter: Simonas Savickas
Date: Tuesday, Sep 19, 2023, 11:45 AM – 1:00 PM
Session: PP03
Presenter: Veronique Laforte
Date: Tuesday, June 6
Topic area: Peptides: Targeted and Quantitative Analysis
Presenter: Simonas Savickas
Session: Poster Session B
Date: August 31 and September 1
In this seminar hosted by Thermo Scientific during US HUPO 2020, we show how to combine Thermo Scientific SureQuant acquisition method with Biognosys PQ500 Peptide Kit and SpectroDive (Biognosys software for targeted proteomics). This application is a plug-and-play, out of the box solution to provide unmatched sensitivity for plasma proteomics samples, resulting in more identifications of low abundant proteins. In addition, the use of a spike-in approach like this allows combining results from different sites, cohorts or acquisition dates without the unwanted batch effects.
The PlasmaDeepDive manual is designed to support users. It provides Kit technicalities, panel information, sample preparation protocol, and recommended spike-in amounts for the automated analysis with our targeted proteomics software SpectroDive
PlasmaDeepDive™ Peptides Manual
The PlasmaDive manual is designed to support users. It provides Kit technicalities, panel information, sample preparation protocol, and recommended spike-in amounts for the automated analysis with our targeted proteomics software SpectroDive
Our PQ500™ Reference Peptides kit offers the absolute quantification of hundreds of human plasma proteins. Here, Monika Puchalska from our Product Support team takes you through how to perform analyses with PQ500 using SpectroDive, our analysis software for targeted proteomics.
Targeted proteomics focuses on the measurement of a selected set of proteins that need to be quantified with high sensitivity, quantitative accuracy, and reproducibility. With SpectroDive 10, it is easier than ever to quantify target proteins thanks to a streamlined panel generation process and reliable automated peptide identification. We are hosting two speakers as part of this seminar.
In our first presentation, Tejas Gandhi from Biognosys will introduce the new, seamless SureQuant integration and demonstrate how SpectroDive can boost your productivity for targeted proteomics workflows, especially when analyzing large-scale datasets.
In the second presentation, Simone Di Sanzo from Alessandro Ori’s lab will share their latest research on mapping sites of carboxymethyllysine modification in proteins to reveal associated consequences for proteostasis and cell proliferation. Posttranslational mechanisms play a key role in modifying the abundance and function of cellular proteins. Among these, modification by advanced glycation end products (AGEs) has been shown to accumulate during aging and age-associated diseases but specific protein targets remain largely unexplored. The Ori lab devised a proteomic strategy to identify specific sites of carboxymethyllysine (CML) modification, one of the most abundant AGEs, and precisely quantify changes of abundance in a site-specific manner by PRM.
Biognosys AG
Wagistrasse 21
8952 Schlieren
Switzerland
Phone: +41 44 738 20 40
US Offices
Biognosys Inc
1 Broadway, 5th Floor
Cambridge, MA 02142
United States
